ReviewPediatric surgery international2026
Antibiotic prophylaxis in pediatric surgery: when more is not better-or safer.
Review in Pediatric surgery international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAntibiotic resistance is a major public health concern. While surgical antibiotic prophylaxis (SAP) reduces surgical site infections (SSIs), inappropriate use may cause harm. This study evaluates the impact of SAP appropriateness and compares beta-lactam versus non-beta-lactam antibiotic use in pediatric surgery.
methodsA retrospective cohort analysis was conducted using ACS NSQIP Pediatric data (2021-2023). Exclusions included preexisting infections, malignancy, immunodeficiencies, and emergent surgeries. SAP appropriateness was classified according to NSQIP guidelines. Logistic regression assessed association between SAP categories and postoperative infections, presented as odds ratios (ORs) and 95% confidence intervals (CIs).
resultsOf 189,111 patients, 87.5% received SAP, 10.2% were overtreated, and 3.9% undertreated. SSIs occurred in 1.9%. Compared to appropriate use, undertreatment was associated with higher odds of SSI (OR: 1.4; 95% CI: 1.2-1.7), sepsis (1.6; 1.1-2.2), C. difficile colitis (2.5; 1.2-5.5), and UTI (1.8; 1.2-2.5). Overtreatment was linked to lower odds of UTI (0.7; 0.5-0.8). Non-beta-lactam antibiotics had higher odds of pneumonia (1.4; 1.0-2.0; p = 0.047) compared to beta-lactam antibiotics.
conclusionAppropriate SAP is crucial in minimizing postoperative infections. These results underscore the importance of antibiotic selection among pediatric surgical patients.
Indexed as
Identifiers
41521361What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.